Barbara O. P.
- Country
- Austria
- Department
- Division of Endocrinology and Diabetology
Research Overview
- Evaluation of Efficacy, Tolerability, and Safety of Spironolactone, Pioglitazone, and Metformin in Adolescents and Young Adults with Polycystic Ovary Syndrome
- Efficacy and Safety Evaluation of Debio 4126, a 12-Week Octreotide Formulation, in Acromegaly Patients Previously Treated with Somatostatin Analogs
Data & Insights
Has run more than one trial at 1 of 54 partner sites.
Specializations
Reproductive Health
Specialized in investigating therapeutic approaches for polycystic ovary syndrome (PCOS), particularly focusing on treatment options for adolescent girls and young adult women.
- Hormonal Disorders
- Ovulation Regulation
- Reproductive Endocrinology
Expertise in evaluating combination therapies for reproductive health management in young female populations.
Endocrine Medicine
Conducts research in endocrine system disorders affecting reproductive function, with particular attention to hormonal imbalances in young women.
- Metabolic Regulation
- Hormonal Therapy
- Endocrine Disorders
Focuses on innovative therapeutic combinations to address complex endocrine conditions.
Adolescent Medicine
Specializes in adolescent and young adult healthcare, particularly in treating reproductive disorders during crucial developmental stages.
- Youth Healthcare
- Developmental Medicine
- Age-Specific Treatments
Dedicated to developing targeted therapeutic solutions for young female patients.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.